Novel Insights into Liver Injury: Mechanisms, Pathophysiology, and Therapeutic Strategies

Articles

ORIGINAL RESEARCH

Published on 21 Nov 2024

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

ORIGINAL RESEARCH

Published on 08 Jul 2024

FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate

ORIGINAL RESEARCH

Published on 28 Mar 2024

Comprehensive analysis of brain injury parameters in a preclinical porcine model of acute liver failure

ORIGINAL RESEARCH

Published on 26 Mar 2024

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity

REVIEW

Published on 20 Mar 2024

Immune regulation and therapeutic application of T regulatory cells in liver diseases

ORIGINAL RESEARCH

Published on 23 Feb 2024

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

Share on

Frontiers in Medicine

Submit your idea

Articles

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate

Comprehensive analysis of brain injury parameters in a preclinical porcine model of acute liver failure

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity

Immune regulation and therapeutic application of T regulatory cells in liver diseases

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

Frontiers in Medicine